The original, randomized, open label study, which enrolled 20 outpatient men with cirrhosis and recurrent HE receiving standard -
of - care (SOC) treatment, had previously reported that a single FMT enema after antibiotic pretreatment improved cognitive function at Day 20 and reduced HE episodes and hospitalizations
over the following 5
months compared with SOC.1 The long - term outcomes
of this study, which were presented today at The International Liver Congress ™ 2018 in Paris, France, demonstrated
sustained and statistically significant reductions in the
number of HE episodes and hospitalizations as well as improvements in cognitive function
over 1 year in the men who received FMT compared with the control group.
Over the coming
months, we will continue to reach out to the community and businesses asking for everyone's help so that we can
sustain our live release
numbers of at least 90 % (and hopefully more) into the future.